Recent MDGL Stock Price | MDGL Stock Predictions | |
$228.34 | +66.56% |
$380.33 |
Recent MDGL Analyst Ratings Breakdown, Making MDGL Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 12 | 12 | 11 | 11 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.29 | 1.29 | 1.31 | 1.31 |
For the MDGL stock predictions from the analysts covering Madrigal Pharmaceuticals Inc, we have collected all of the individual MDGL stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 12 different analysts covering MDGL (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MDGL stock predictions may vary widely, another useful metric to consider is the median MDGL stock prediction, which represents the price at which half of the analysts
made MDGL stock predictions that were higher and half made MDGL stock predictions that were lower. This makes for a different take on the MDGL stock predictions out there, as compared to average or mean.
And that median across all the individual MDGL stock predictions was: $390.0 as of 2024-04-18.
The very highest of the MDGL stock predictions for one year price target was $425.0, while the very lowest of the MDGL stock predictions in the analyst group was
$270.0 (with a standard deviation of $41.108). Get the latest Zacks research report on MDGL — FREE
Find out: MDGL next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CASA Stock Predictions
NAV Stock Predictions
EPAM Stock Predictions
PCSB Stock Predictions
INN Stock Predictions
CEO Stock Predictions
IBKR Stock Predictions
THC Stock Predictions
CHCT Stock Predictions
|
|
Strong Buy (3.71 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |